The first effects of the arrival of the European Medicines Agency EMA are already being felt.
The EMA effect is also good news for scientific research. Director Bart Klijsen of IXA VU-VUmc says, “In order to bring research to society, cooperation and participation with companies is indispensable. This requires a mature ecosystem. That is why the arrival of EMA is positive for the Netherlands and for the region. Although not all contacts are directly related to EMA, there is a lot more interest from the medical industry in Amsterdam.”
Read the full Parool article of Herman Stil, Artikel-Parool-Als-EMA-over-de-dam-is…..pdf
PULSE Sport, a start-up from the Demonstrator Lab, has reached a significant milestone by winning the prestigious 14th Dutch Sports Innovation Award. The company’s flagship product, a cutting-edge athlete management system, integrates advanced software and artificial intelligence to revolutionize athlete health and performance monitoring. About the Innovation PULSE Sport’s athlete management system provides a holistic […]
NewsVU-AMS is on a mission to revolutionize how we understand and manage stress-related health issues. Now an official VU spin-off, there are big plans for clinical applications. Founder of VU AMS Martin Gevonden explains: “We offer researchers autonomic biomarkers that are valid, reliable and easy to use, without getting under the skin.” After thriving in […]
NewsAmsterdam researchers have secured Biotech Booster funding for a total of six projects, that include a promising cancer treatment, a new diagnostic method for Alzheimer’s Disease, an implant helping blindness, lab innovation in biotechnology, and a nutritional intervention for mental health. The researchers will develop a solid business case for their innovations in the time […]
News